Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lisa Pfeuffer"'
Autor:
Lisa Pfeuffer, Viola Siegert, Julia Frede, Leonie Rieger, Riccardo Trozzo, Niklas de Andrade Krätzig, Sandra Ring, Shamim Sarhadi, Nicole Beck, Stefan Niedermeier, Mar Abril-Gil, Mohamed Elbahloul, Marianne Remke, Katja Steiger, Ruth Eichner, Julia Jellusova, Roland Rad, Florian Bassermann, Christof Winter, Jürgen Ruland, Maike Buchner
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract B-cell malignancies, such as chronic lymphocytic leukemia (CLL) and multiple myeloma (MM), remain incurable, with MM particularly prone to relapse. Our study introduces a novel mouse model with active RANK signaling and the TCL1 oncogene, di
Externí odkaz:
https://doaj.org/article/5d14702a54c246dbbd1aa8836923caa2
Autor:
Veronika Ecker, Martina Stumpf, Lisa Brandmeier, Tanja Neumayer, Lisa Pfeuffer, Thomas Engleitner, Ingo Ringshausen, Nina Nelson, Manfred Jücker, Stefan Wanninger, Thorsten Zenz, Clemens Wendtner, Katrin Manske, Katja Steiger, Roland Rad, Markus Müschen, Jürgen Ruland, Maike Buchner
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-17 (2021)
Current therapeutic approaches in chronic lymphocytic leukemia (CLL) focus on the suppression of PI3K/AKT signaling. Here, the authors show that CLL cells are vulnerable to hyperactivation of the PI3K/AKT signaling pathway and suggest this as a promi
Externí odkaz:
https://doaj.org/article/48da348450fd4d8c8348861c88888a7b
Autor:
Hye Kyung Lee, Manuela A. Hoechstetter, Maike Buchner, Trang Thu Pham, Jin Won Huh, Katharina Müller, Sabine Zange, Heiner von Buttlar, Philipp Girl, Roman Wölfel, Lisa Brandmeier, Lisa Pfeuffer, Priscilla A. Furth, Clemens-Martin Wendtner, Lothar Hennighausen
Publikováno v:
Blood Advances. 7:2214-2227
Patients with chronic lymphocytic leukemia (CLL) treated with B-cell pathway inhibitors and anti-CD20 antibodies exhibit low humoral response rates following SARS-CoV-2 vaccination. To investigate this observation, a prospective single-institution st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a056e5f558726883cd23dec8c718407e
https://doi.org/10.1182/bloodadvances.2022008445
https://doi.org/10.1182/bloodadvances.2022008445
Autor:
Veronika Ecker, Lisa Brandmeier, Martina Stumpf, Piero Giansanti, Aida Varela Moreira, Lisa Pfeuffer, Marcel Fens, Junyan Lu, Bernhard Küster, Thomas Engleitner, Simon Heidegger, Ingo Ringshausen, Thorsten Zenz, Clemens Wendtner, Markus Müschen, Jürgen Ruland, Maike Buchner
Despite several potent targeted treatments for chronic lymphocytic leukemia (CLL), the clinical challenge of treating drug-resistant disease is emerging. In this study, we discovered that the dual-specific phosphatases DUSP1 and DUSP6 are required to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b32e9a6e97279a251062a7c002825e6
https://doi.org/10.21203/rs.3.rs-2481423/v1
https://doi.org/10.21203/rs.3.rs-2481423/v1
Autor:
Hye Kyung Lee, Manuela A. Hoechstetter, Maike Buchner, Trang Thu Pham, Jin Won Huh, Katharina Müller, Sabine Zange, Heiner von Buttlar, Philipp Girl, Roman Wölfel, Lisa Brandmeier, Lisa Pfeuffer, Priscilla A. Furth, Clemens-Martin Wendtner, Lothar Hennighausen
Publikováno v:
medRxiv
Patients with chronic lymphocytic leukemia (CLL) treated with B-cell pathway inhibitors and anti-CD20 antibodies exhibit low humoral response rate (RR) following SARS-CoV-2 vaccination. To investigate the relationship between the initial transcriptio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::120666c1d986af05b570304a4902434e
https://doi.org/10.1101/2022.09.21.22280205
https://doi.org/10.1101/2022.09.21.22280205